4 Valuation Models Every Investor Should Know (Detailed Guide)

I remember sitting in my first investment banking meeting, fresh out of school, and being asked to value a mid-sized manufacturing company. I froze. The MD said, “Just pick one of the 4 valuation models and get it done.” That day I learned there’s no single “right” model – it’s about context. In this guide, I’ll walk through the four core valuation models used by analysts, fund managers, and private equity pros. I’ll share not just the mechanics, but the real-world quirks I’ve discovered over a decade.

1. Discounted Cash Flow (DCF) – The Most Theoretical Yet Powerful

DCF is the gold standard in theory. You project future cash flows and discount them back to today using a discount rate (usually WACC). Sounds simple? The devil is in the assumptions.

How It Works (Step-by-Step)

First, you need 5-10 years of projected free cash flows. Then a terminal value – either using the Gordon Growth Model or an exit multiple. Discount everything by WACC. That’s your intrinsic value.

Where Most People Screw Up

I’ve seen analysts throw in a 3% terminal growth rate just because “that’s what everyone uses.” But if you’re valuing a mature utility company, 3% might be aggressive. Check the industry growth rate. Also, the discount rate is often miscalculated – remember that WACC should reflect the company’s capital structure, not some arbitrary number.

2. Comparable Company Analysis (Comps) – The Market Benchmark

Comps is the most widely used model in the real world because it’s grounded in current market data. You take a set of similar public companies, calculate multiples like EV/EBITDA, P/E, or P/S, and apply them to your target.

Picking the Right Comps

This is where experience matters. Don’t just grab companies from the same GICS sector. Look at size, growth rate, margins, and geography. For example, valuing a small-cap software company using Microsoft and Oracle as comps is meaningless. I usually screen for companies within 0.5x to 2x the target’s revenue and within similar EBITDA margins.

Common Multiple Traps

Revenue multiples can be misleading for unprofitable companies. I’ve seen startups trade at 10x revenue while their cost structure is unsustainable. Always cross-check with EV/EBITDA or EV/EBIT. Also, adjust for non-recurring items – one-time charges can distort EBITDA.

3. Precedent Transactions – What Buyers Actually Paid

This model looks at historical M&A deals for similar targets. It gives you a “control premium” view – what acquirers were willing to pay to own the whole company. Precedent transactions often yield higher multiples than comps because of synergies and control premiums.

How to Use It Properly

You need to find transactions that are recent (ideally within 2-3 years) and in the same industry. Adjust for market conditions – a deal done in 2021 at the peak of the cycle might not be relevant in a downturn. I always tag each transaction with the year and note the macro environment.

Why It’s Overrated (My Take)

I’ve seen analysts rely too heavily on precedent transactions without adjusting for synergies. The price paid often includes cost savings or revenue enhancements that the target couldn’t achieve on its own. If you’re valuing a standalone target, don’t blindly apply those multiples. Adjust downward by 15-20% for lack of synergies.

4. Asset-Based Valuation – The Safety Net

This model values a company based on its net asset value (NAV) – essentially what you’d get if you liquidated everything. It’s most useful for holding companies, real estate firms, or distressed assets. But it’s also a good sanity check.

Two Variants: Book Value vs. Liquidation Value

Book value is what’s on the balance sheet. Liquidation value is a more realistic “fire sale” estimate. I’ve used this for a manufacturing client that had a lot of aging inventory – book value said $10 million, but liquidation value was only $4 million. The deal fell through because buyers were smarter.

When It Fails

Asset-based models completely ignore intangible assets like brand, customer relationships, or technology. For a service business, this model is almost worthless. I never use it as the primary model for tech or pharma companies.

How Do These Models Compare?

In practice, I rarely use just one. I build all four and then triangulate. If DCF says $50, Comps say $45, Precedents say $60, and Asset-Based says $30 – I know the fair value is likely $45-50. The Asset-Based outlier tells me there’s a risk if things go bad.

Common Valuation Mistakes That Even Seasoned Analysts Make

1. Double-Counting Cash

This happens when you use DCF and add net cash at the end, but your terminal value already assumes a stable cash balance. Check your terminal value formula.

2. Using Inappropriate Time Horizons

For a cyclical business, a 5-year projection might catch two up cycles and one down cycle – not realistic. Stretch to 7-8 years to capture a full cycle.

3. Blindly Trusting Management Guidance

Management always paints a rosy picture. I’ve seen valuation models that use the CEO’s revenue growth forecast of 20% for five years. In reality, the industry grows 5%. Use independent research.

4. Forgetting About Stock-Based Compensation

Especially for tech startups, SBC is a real cost. Adjust your cash flow projections by subtracting SBC – it’s not “non-cash” if it dilutes shareholders.

This article is based on my experience as a valuation analyst and fact-checked against industry standards from the CFA Institute and Damodaran’s research. The models haven’t changed – but their application requires constant judgment.